drugset / Trial / NCT04924322
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Phase 2/3
Recruiting
258 enrolled
Yale University
BJC HealthCare · collabChildren's Hospital Colorado · collabChildren's Hospital of Illinois at Peoria · collabChildren's Hospital of Philadelphia · collabChildren's of Alabama · collabEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collabGolisano Children's Hospital · collabHassenfeld Children's Hospital · collabJohns Hopkins All Children's Hospital · collabMaria Fareri Children's Hospital · collabMedical College of Wisconsin · collabNationwide Children's Hospital · collabNew York Presbyterian Hospital · collabPenn State University · collabUniversity of Iowa · collabUniversity of Oklahoma · collab
RandomizedParallel-groupSingle-blindPrevention
Summary
The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.
Timeline
- Start
- 2022-05-11
- Primary completion
- 2027-04-30
- Completion
- 2027-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enoxaparin sodium | Other / unclassified | 0.5 mg/kg | — |
| Subject | Enoxaparin sodium | Other / unclassified | 1.5 mg/kg | — |